Peer Review Process

Manuscripts submitted to the International Journal of Biological and Drug Research (IJBDR) are reviewed by the blind peer review process. The manuscript first undergoes an editorial/technical review to determine the eligibility and appropriateness of the manuscript as per the journal’s scope. Manuscripts rejected at this stage are those that are insufficiently original, have serious scientific flaws, have poor grammar or English language, are outside the aims and scope of the journal, or are not written as per the journal's guidelines. After analyzing the appropriateness of the manuscript, it will be forwarded for review.

• Generally, all the manuscripts are reviewed by at least two external experts in the respective subject area. The report of the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript, but the ultimate responsibility for acceptance or rejection lies with the Editor-In-Chief. 
• Editor-In-Chief makes the final decision on every manuscript submitted to IJBDR.
• Editor-in-Chief can seek advice from one or more advisory board members for their suggestions on a manuscript, before making the final decision.
• Associate editors provide administrative support to maintain the integrity of the peer-review process.